World Automated Microbiology Market Report 2018

The "2018 World Automated Microbiology Market" report has been added to Research And Markets' offering.

'2018 World Automated Microbiology Market: Emerging Opportunities in the Americas, EMEA, APAC - A 74-Country Analysis - Supplier Shares and Strategies, Volume and Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening and Immunodiagnostic Tests, Technology and Instrumentation Review'

This new 74-country survey provides granular data and analysis not available from any other published source. The survey is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the automated microbiology market during the next five years.

The report examines key trends; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for 100 molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures; profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.

Rationale

The level of automation in the microbiology laboratory has been lagging behind that of other major clinical laboratory segments, such as chemistry and hematology. The slow acceptance of the technology is in part due to the complexity of developing automation suitable for microbiology tests. The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems. The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies. The acquisition of automation in microbiology has been slowed by forces less easily identifiable than the effects of various reimbursement plans. Some laboratorians still believe that current instrumentation is not the ultimate technology and expect better automation on the horizon.

The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expense are coming under severe scrutiny worldwide.

Specimen Types

Urine

Sterile Fluids: Blood, Serum, CSF

Throat Swabs, Respiratory Secretions

Genital Secretions

Stool

Abscess/Wound

Sputum

Saliva

Applications

Microbial Identification

Antibiotic Susceptibility

Urine Screening

Blood Cultures

Competitive Assessments

Abbott

Affymetrix/Thermo Fisher

Becton Dickinson

Biokit

bioMerieux

Bio-Rad

Biotest

CellMark Forensics/LabCorp

Cepheid

Decode

Diadexus

Diamedix

DiaSorin

Elitech Group

Grifols

Hologic/Gen-Probe

ID Biomedical/GSK

Illumina

Kreatech/Leica

Li-Cor Biosciences

Lonza

Monogram Biosciences

Myriad Genetics

Qiagen

Roche

Scienion

Sequenom

SeraCare

Shimadzu

Siemens

Sierra Molecular

Takara Bio

Tecan

Wallac/PE

Wako

Register as Visitor to CPhI China 2018!